Literature DB >> 12033730

Biochemical properties of a keratan sulphate/chondroitin sulphate proteoglycan expressed in primate pluripotent stem cells.

Susan Cooper1, William Bennett, Jessica Andrade, Benjamin E Reubinoff, James Thomson, Martin F Pera.   

Abstract

We previously identified a pericellular matrix keratan sulphate/chondroitin sulphate proteoglycan present on the surface of human embryonal carcinoma stem cells, cells whose differentiation mimics early development. Antibodies reactive with various epitopes on this molecule define a cluster of differentiation markers for primate pluripotent stem cells. We describe the purification of a form of this molecule which is secreted or shed into the culture medium. Biochemical analysis of the secreted form of this molecule shows that the monomeric form, whilst containing keratan sulphate, resembles mucins in its structure and its modification with O-linked carbohydrate. Immunofluorescence and immunoblotting data show that monkey and human pluripotent stem cells react with antibodies directed against epitopes on either carbohydrate side chains or the protein core of the molecule.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12033730      PMCID: PMC1570689          DOI: 10.1046/j.1469-7580.2002.00034.x

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  14 in total

1.  Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro.

Authors:  B E Reubinoff; M F Pera; C Y Fong; A Trounson; A Bongso
Journal:  Nat Biotechnol       Date:  2000-04       Impact factor: 54.908

2.  The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan.

Authors:  G Badcock; C Pigott; J Goepel; P W Andrews
Journal:  Cancer Res       Date:  1999-09-15       Impact factor: 12.701

Review 3.  Keratan sulfate: structure, biosynthesis, and function.

Authors:  J L Funderburgh
Journal:  Glycobiology       Date:  2000-10       Impact factor: 4.313

4.  Isolation and characterization of a multipotent clone of human embryonal carcinoma cells.

Authors:  M F Pera; S Cooper; J Mills; J M Parrington
Journal:  Differentiation       Date:  1989-10       Impact factor: 3.880

5.  Analysis of cell-differentiation lineage in human teratomas using new monoclonal antibodies to cytostructural antigens of embryonal carcinoma cells.

Authors:  M F Pera; M J Blasco-Lafita; S Cooper; M Mason; J Mills; P Monaghan
Journal:  Differentiation       Date:  1988-12       Impact factor: 3.880

6.  Immunohistochemical and biochemical characterisation of the expression of a human embryonal carcinoma cell proteoglycan antigen in human germ cell tumours and other tissues.

Authors:  M D Mason; M F Pera
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

Review 7.  Human teratocarcinomas.

Authors:  P W Andrews
Journal:  Biochim Biophys Acta       Date:  1988-08-03

8.  Hepatocytic transcription factor expression in human embryonal carcinoma and yolk sac carcinoma cell lines: expression of HNF-3 alpha in models of early endodermal cell differentiation.

Authors:  S Roach; W Schmid; M F Pera
Journal:  Exp Cell Res       Date:  1994-11       Impact factor: 3.905

9.  A novel keratan sulphate proteoglycan from a human embryonal carcinoma cell line.

Authors:  S Cooper; M F Pera; W Bennett; J T Finch
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

Review 10.  Human embryonic stem cells.

Authors:  M F Pera; B Reubinoff; A Trounson
Journal:  J Cell Sci       Date:  2000-01       Impact factor: 5.285

View more
  7 in total

Review 1.  Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.

Authors:  Hidenao Toyoda; Yuko Nagai; Aya Kojima; Akiko Kinoshita-Toyoda
Journal:  Glycoconj J       Date:  2017-01-11       Impact factor: 2.916

Review 2.  Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.

Authors:  Hidenao Toyoda; Yuko Nagai; Aya Kojima; Akiko Kinoshita-Toyoda
Journal:  Glycoconj J       Date:  2017-10-05       Impact factor: 2.916

3.  Lectin binding profiles of SSEA-4 enriched, pluripotent human embryonic stem cell surfaces.

Authors:  Alison Venable; Maisam Mitalipova; Ian Lyons; Karen Jones; Soojung Shin; Michael Pierce; Steven Stice
Journal:  BMC Dev Biol       Date:  2005-07-21       Impact factor: 1.978

4.  Transcriptional analysis of early lineage commitment in human embryonic stem cells.

Authors:  Andrew L Laslett; Sean Grimmond; Brooke Gardiner; Lincon Stamp; Adelia Lin; Susan M Hawes; Sam Wormald; David Nikolic-Paterson; David Haylock; Martin F Pera
Journal:  BMC Dev Biol       Date:  2007-03-02       Impact factor: 1.978

5.  WIKI4, a novel inhibitor of tankyrase and Wnt/ß-catenin signaling.

Authors:  Richard G James; Kathryn C Davidson; Katherine A Bosch; Travis L Biechele; Nicholas C Robin; Russell J Taylor; Michael B Major; Nathan D Camp; Kerry Fowler; Timothy J Martins; Randall T Moon
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

Review 6.  Keratan sulfate, a complex glycosaminoglycan with unique functional capability.

Authors:  Bruce Caterson; James Melrose
Journal:  Glycobiology       Date:  2018-04-01       Impact factor: 4.313

7.  Generation and trapping of a mesoderm biased state of human pluripotency.

Authors:  Dylan Stavish; Charlotta Böiers; Christopher Price; Thomas J R Frith; Jason Halliwell; Ingrid Saldaña-Guerrero; Jason Wray; John Brown; Jonathon Carr; Chela James; Ivana Barbaric; Peter W Andrews; Tariq Enver
Journal:  Nat Commun       Date:  2020-10-05       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.